Article
High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.
Scientific reports - 12 Jan 2018
Steeghs Elisabeth M P, Bakker Marjolein, Hoogkamer Alex Q, Boer Judith M, Hartman Quirine J, Stalpers Femke, Escherich Gabriele, de Haas Valerie, de Groot-Kruseman Hester A, Pieters Rob, den Boer Monique L
Abstract excerpt
Approximately 25% of the pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL) cases are genetically unclassified. More thorough elucidation of the pathobiology of these genetically unclassified ('B-other') cases may identify novel treatment options. We analyzed gene expression profiles of 572 pediatric BCP-ALL cases, representing all major ALL subtypes. High expression of STAP1, an adaptor protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
